[O2Micro Revises First Quarter 2019 Financial Guidance GEORGE TOWN, Grand Cayman, March 29, 2019 (GLOBE NEWSWIRE) -- O2Micro® International Limited (NASDAQ: OIIM), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, today revised its guidanc]
[x ¨ x Large accelerated filer ¨ Accelerated filer x Non-accelerated filer ¨ Smaller reporting company x Emerging growth company ¨ ¨ ¨ x 2018 ANNUAL REPORT ON FORM 10-K TABLE OF CONTENTS Page] [Loan Contract Party A (Lender): Wuhan KangBo Biotechnology Co., Ltd. Party B (Borrower): Wuhan Kingold Jewe]
[ý No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies:]
[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ x ] Form 10-K [ For Period Ended: December 31, 2018 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transi]
[ý No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies:]
[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ x ] Form 10-K [ For Period Ended: December 31, 2018 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transi]
